Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study
Author(s) -
Cristina Firanescu,
Elisabeth J. Martens,
Jacques P.A.M. Schönberger,
Mohamed A. Soliman Hamad,
Albert H.M. van Straten
Publication year - 2009
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2009.05.032
Subject(s) - medicine , clopidogrel , perioperative , discontinuation , surgery , anesthesia , coronary artery bypass surgery , blood transfusion , cardiac surgery , artery , prospective cohort study , aspirin
The optimal timing for discontinuation of clopidogrel before surgery remains under debate. The purpose of this study is to determine the effect of preoperative clopidogrel administration on postoperative blood loss and the total requirements of homologous blood products after coronary artery bypass grafting (CABG). We also evaluated the perioperative complications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom